Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Clinical trial NCT02452216 · COMPLETED

Trial details

NCT number: NCT02452216
Sponsor: Michael Iv
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Brain Injury Central Nervous System Degenerative Disorder Central Nervous System Infectious Disorder Central Nervous System Vascular Malformation Hemorrhagic Cerebrovascular Accident Ischemic Cerebrovascular Accident Primary Brain Neoplasm Brain Cancer Brain Tumors

Start date: 2015-06-10
Primary completion: 2017-01-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.